Report cover image

Global & Australia Interventional Cardiology Devices Market to 2033

Published Aug 25, 2025
Length 122 Pages
SKU # BMKS20334705

Description

The market for interventional cardiology devices in Australia is well-established and driven by innovation, bolstered by a robust healthcare system, sophisticated clinical infrastructure, and high standards of procedure. The nation boasts a comprehensive network of both public and private hospitals that conduct a variety of minimally invasive cardiac procedures, with percutaneous coronary interventions (PCI) being a fundamental aspect of standard care. The use of drug-eluting stents, imaging-guided interventions, and radial access techniques is prevalent, adhering to both national and international clinical guidelines.

Product approvals and market launches are crucial in influencing the landscape of interventional cardiology in Australia. The Therapeutic Goods Administration (TGA) provides a clear regulatory framework that facilitates the prompt introduction of advanced interventional devices. For example, in September 2024, Sahajanand Medical Technologies (SMT), a global leader in innovative medical devices, announced that its premier drug-eluting stent (DES), Supraflex Cruz, has been granted approval by the TGA in Australia.

Table of Contents

122 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. Australia Interventional Cardiology Devices Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Interventional Cardiology Devices Market Key Market Dynamics
5.1 Interventional Cardiology Devices Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. Australia Interventional Cardiology Devices Market – Analysis
6.1 Australia Interventional Cardiology Devices Market Revenue (US$ Million), 2022–2033
6.2 Australia Interventional Cardiology Devices Market Revenue and Forecast Analysis
7. Australia Interventional Cardiology Devices Market Analysis – by Product Type
7.1 Australia Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Product Type
8. Australia Interventional Cardiology Devices Market Analysis – by Material Type
8.1 Australia Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Material Type
9. Australia Interventional Cardiology Devices Market Analysis – by Application
9.1 Australia Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Application
10. Australia Interventional Cardiology Devices Market Analysis – by Indication
10.1 Australia Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Indication
11. Australia Interventional Cardiology Devices Market Analysis – by End User
11.1 Australia Interventional Cardiology Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by End User
12. Competitive Landscape
12.1Heat Map Analysis by Key Players
12.1Company Positioning and Concentration
13. Industry Landscape
13.1Overview
13.2Market Initiative
13.2Partnerships and Collaborations
13.2Other Developments
14. Company Profiles
14.1 Medtronic Plc
14.1. 1 Key Facts
14.1. 2 Business Description
14.1. 3 Products and Services
14.1. 4 Financial Overview
14.1. 5 SWOT Analysis
14.1. 6 Key Developments
14.2 Boston Scientific Corp
14.2. 1 Key Facts
14.2. 2 Business Description
14.2. 3 Products and Services
14.2. 4 Financial Overview
14.2. 5 SWOT Analysis
14.2. 6 Key Developments
14.3 Abbott Laboratories
14.3. 1 Key Facts
14.3. 2 Business Description
14.3. 3 Products and Services
14.3. 4 Financial Overview
14.3. 5 SWOT Analysis
14.3. 6 Key Developments
14.4 B Braun SE
14.4. 1 Key Facts
14.4. 2 Business Description
14.4. 3 Products and Services
14.4. 4 Financial Overview
14.4. 5 SWOT Analysis
14.4. 6 Key Developments
14.5 Terumo Corp
14.5. 1 Key Facts
14.5. 2 Business Description
14.5. 3 Products and Services
14.5. 4 Financial Overview
14.5. 5 SWOT Analysis
14.5. 6 Key Developments
14.6 Edwards Lifesciences Corp
14.6. 1 Key Facts
14.6. 2 Business Description
14.6. 3 Products and Services
14.6. 4 Financial Overview
14.6. 5 SWOT Analysis
14.6. 6 Key Developments
14.7 Teleflex Inc
14.7. 1 Key Facts
14.7. 2 Business Description
14.7. 3 Products and Services
14.7. 4 Financial Overview
14.7. 5 SWOT Analysis
14.7. 6 Key Developments
14.8 Lepu Medical Technology Beijing Co Ltd
14.8. 1 Key Facts
14.8. 2 Business Description
14.8. 3 Products and Services
14.8. 4 Financial Overview
14.8. 5 SWOT Analysis
14.8. 6 Key Developments
14.9 W L Gore and Associates Inc
14.9. 1 Key Facts
14.9. 2 Business Description
14.9. 3 Products and Services
14.9. 4 Financial Overview
14.9. 5 SWOT Analysis
14.9. 6 Key Developments
14.10 Meril Life Sciences Pvt Ltd
14.10. 1 Key Facts
14.10. 2 Business Description
14.10. 3 Products and Services
14.10. 4 Financial Overview
14.10. 5 SWOT Analysis
14.10. 6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.